BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24211782)

  • 1. Nuclear localization of bradykinin B(2) receptors reflects binding to the nuclear envelope protein lamin C.
    Takano M; Kanoh A; Amako K; Otani M; Sano K; Kanazawa-Hamada M; Matsuyama S
    Eur J Pharmacol; 2014 Jan; 723():507-14. PubMed ID: 24211782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular and nuclear bradykinin B2 receptors.
    Takano M; Matsuyama S
    Eur J Pharmacol; 2014 Jun; 732():169-72. PubMed ID: 24657278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.
    Savard M; Barbaz D; Bélanger S; Müller-Esterl W; Bkaily G; D'orléans-Juste P; Coté J; Bovenzi V; Gobeil F
    J Cell Physiol; 2008 Jul; 216(1):234-44. PubMed ID: 18264983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lamin CxxM motif promotes nuclear membrane growth.
    Prüfert K; Vogel A; Krohne G
    J Cell Sci; 2004 Dec; 117(Pt 25):6105-16. PubMed ID: 15546914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor.
    Shivakumar BR; Wang Z; Hammond TG; Harris RC
    Cell Biochem Funct; 2005; 23(3):195-204. PubMed ID: 15376229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear titin interacts with A- and B-type lamins in vitro and in vivo.
    Zastrow MS; Flaherty DB; Benian GM; Wilson KL
    J Cell Sci; 2006 Jan; 119(Pt 2):239-49. PubMed ID: 16410549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
    Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
    J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms.
    Hembree TN; Leeb-Lundberg LM
    J Cell Physiol; 1996 Nov; 169(2):248-55. PubMed ID: 8908192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts.
    Lee CH; Shieh DC; Tzeng CY; Chen CP; Wang SP; Chiu YC; Huang CY; Hsu CJ; Fong YC; Tang CH
    Mol Immunol; 2008 Aug; 45(14):3693-702. PubMed ID: 18621420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of N-terminal and C-terminal Arg residues from BK on interaction with kinin B2 receptor.
    Filippelli-Silva R; Martin RP; Rodrigues ES; Nakaie CR; Oliveira L; Pesquero JB; Shimuta SI
    Biol Chem; 2016 Apr; 397(4):305-14. PubMed ID: 26584354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of fluorescent bradykinin analogs: application to imaging of B2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme.
    Gera L; Bawolak MT; Roy C; Lodge R; Marceau F
    J Pharmacol Exp Ther; 2011 Apr; 337(1):33-41. PubMed ID: 21205920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.
    Chen Z; Deddish PA; Minshall RD; Becker RP; Erdös EG; Tan F
    FASEB J; 2006 Nov; 20(13):2261-70. PubMed ID: 17077303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptor.
    Quitterer U; Pohl A; Langer A; Koller S; Abdalla S
    Biochem Biophys Res Commun; 2011 Jun; 409(3):544-9. PubMed ID: 21600887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal fusion of eGFP to the bradykinin B2 receptor strongly affects down-regulation but not receptor internalization or signaling.
    Kalatskaya I; Schüssler S; Seidl C; Jochum M; Faussner A
    Biol Chem; 2006 May; 387(5):603-10. PubMed ID: 16740132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C.
    Ivorra C; Kubicek M; González JM; Sanz-González SM; Alvarez-Barrientos A; O'Connor JE; Burke B; Andrés V
    Genes Dev; 2006 Feb; 20(3):307-20. PubMed ID: 16452503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signaling of dynorphin at κ-opioid receptor/bradykinin B2 receptor heterodimers.
    Ji B; Liu H; Zhang R; Jiang Y; Wang C; Li S; Chen J; Bai B
    Cell Signal; 2017 Feb; 31():66-78. PubMed ID: 28069442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization.
    Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC
    Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lco1 is a novel widely expressed lamin-binding protein in the nuclear interior.
    Vlcek S; Foisner R; Wilson KL
    Exp Cell Res; 2004 Aug; 298(2):499-511. PubMed ID: 15265697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aneuploidies induced upon Lamin B2 depletion are mislocalized in the interphase nucleus.
    Ranade D; Koul S; Thompson J; Prasad KB; Sengupta K
    Chromosoma; 2017 Mar; 126(2):223-244. PubMed ID: 26921073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.